Close

AbbVie (ABBV) Updates on Glecaprevir/Pibrentasvir Treatment Regiment in HCV; High SVR12 Rates Noted at 8 Weeks

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. LVS
2. TSM
3. SPY
4. CSX
5. UAL
6. ALK
7. TSLA
8. CCI
9. INFY
10. AA


Go back to AbbVie (ABBV) Updates on Glecaprevir/Pibrentasvir Treatment Regiment in HCV; High SVR12 Rates Noted at 8 Weeks